Tompkins Financial Corp Eli Lilly & CO Transaction History

Tompkins Financial Corp

$953 Million
Q2 2024

A detailed history of Tompkins Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Tompkins Financial Corp holds 31,380 shares of LLY stock, worth $28.3 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

31,380

Previous 30,855 1.7%

Holding current value

$28.3 Million

Previous $24 Million 18.36%

% of portfolio

2.98%

Previous 2.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $380,556 - $477,246	525 Added 1.7%	31,380 $28.4 Million
Q1 2024 Apr 08, 2024	SELL	$592.2 - $792.28 $653,196 - $873,884	-1,103 Reduced 3.45%	30,855 $24 Million
Q4 2023 Jan 08, 2024	SELL	$525.19 - $619.13 $1.49 Million - $1.75 Million	-2,829 Reduced 8.13%	31,958 $18.6 Million
Q3 2023 Nov 20, 2023	BUY	$434.7 - $599.3 $505,556 - $696,985	1,163 Added 3.46%	34,787 $18.7 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $1.05 Million - $1.41 Million	-3,001 Reduced 8.19%	33,624 $15.8 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $237,942 - $279,452	-766 Reduced 2.05%	36,625 $12.6 Million
Q4 2022 Jan 06, 2023	SELL	$321.55 - $374.67 $678,792 - $790,928	-2,111 Reduced 5.34%	37,391 $13.7 Million
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $263,274 - $300,028	-888 Reduced 2.2%	39,502 $12.8 Million
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $169,467 - $198,980	-608 Reduced 1.48%	40,390 $13.1 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $78,621 - $97,706	335 Added 0.82%	40,998 $11.7 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $168,412 - $209,000	-749 Reduced 1.81%	40,663 $11.2 Million
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $498,600 - $613,597	-2,250 Reduced 5.15%	41,412 $9.57 Million
Q1 2021 Jun 09, 2021	BUY	$164.32 - $212.72 $6,408 - $8,296	39 Added 0.09%	43,662 $8.16 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $5.05 Million - $6.68 Million	38,698 Added 785.75%	43,623 $7.37 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $4.73 Million - $6.27 Million	-36,292 Reduced 88.05%	4,925 $683,000
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $16,230 - $18,773	111 Added 0.27%	41,217 $6.1 Million
Q2 2020 Jul 29, 2020	BUY	$136.42 - $164.18 $137,920 - $165,985	1,011 Added 2.52%	41,106 $6.75 Million
Q1 2020 Apr 22, 2020	SELL	$119.05 - $147.35 $186,432 - $230,750	-1,566 Reduced 3.76%	40,095 $5.56 Million
Q4 2019 Jan 22, 2020	BUY	$106.92 - $132.43 $503,165 - $623,215	4,706 Added 12.73%	41,661 $5.48 Million
Q3 2019 Oct 17, 2019	BUY	$106.79 - $116.16 $9,290 - $10,105	87 Added 0.24%	36,955 $4.13 Million
Q2 2019 Jul 17, 2019	BUY	$110.79 - $129.32 $44,316 - $51,728	400 Added 1.1%	36,868 $4.09 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $48,085 - $56,600	-432 Reduced 1.17%	36,468 $4.73 Million
Q1 2019 Apr 17, 2019	BUY	$111.31 - $131.02 $78,473 - $92,369	705 Added 1.95%	36,900 $3.96 Million
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $74,659 - $83,641	-705 Reduced 1.91%	36,195 $4.19 Million
Q3 2018 Oct 18, 2018	BUY	$85.86 - $107.31 $17,172 - $21,462	200 Added 0.54%	36,900 $3.96 Million
Q2 2018 Jul 18, 2018	BUY	$75.7 - $86.88 $69,265 - $79,495	915 Added 2.56%	36,700 $3.13 Million
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $13,432 - $15,855	181 Added 0.51%	35,785 $2.77 Million
Q4 2017 Jan 24, 2018	BUY	$81.94 - $87.89 $50,229 - $53,876	613 Added 1.75%	35,604 $3.01 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $2.7 Million - $2.99 Million	34,991	34,991 $2.99 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Eli Lilly & CO Transaction History